Tcr2 Therapeutics Inc

NASDAQ:TCRR  
16.91
-0.56 (-3.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Tcr2 Therapeutics Inc Stock, NASDAQ:TCRR

100 Binney Street, Suite 710, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.949.5200
Number of Employees: 118

Description

TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It also involves in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle in May 2015 and is headquartered in Cambridge, MA.